PL370488A1 - Preparat złożony inhibitora wymiany sód-wodór kariporidu z inhibitorami ACE dla zapobiegania niewydolności serca i innych związanych z wiekiem dysfunkcji narządów, związanych z wiekiem chorób i dla przedłużenia życia - Google Patents

Preparat złożony inhibitora wymiany sód-wodór kariporidu z inhibitorami ACE dla zapobiegania niewydolności serca i innych związanych z wiekiem dysfunkcji narządów, związanych z wiekiem chorób i dla przedłużenia życia

Info

Publication number
PL370488A1
PL370488A1 PL03370488A PL37048803A PL370488A1 PL 370488 A1 PL370488 A1 PL 370488A1 PL 03370488 A PL03370488 A PL 03370488A PL 37048803 A PL37048803 A PL 37048803A PL 370488 A1 PL370488 A1 PL 370488A1
Authority
PL
Poland
Prior art keywords
age
organs
sodium
heart failure
ace inhibitors
Prior art date
Application number
PL03370488A
Other languages
English (en)
Inventor
Wolfgang Linz
Ursula Schindler
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of PL370488A1 publication Critical patent/PL370488A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL03370488A 2002-02-04 2003-01-22 Preparat złożony inhibitora wymiany sód-wodór kariporidu z inhibitorami ACE dla zapobiegania niewydolności serca i innych związanych z wiekiem dysfunkcji narządów, związanych z wiekiem chorób i dla przedłużenia życia PL370488A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10204571 2002-02-04

Publications (1)

Publication Number Publication Date
PL370488A1 true PL370488A1 (pl) 2005-05-30

Family

ID=27674558

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03370488A PL370488A1 (pl) 2002-02-04 2003-01-22 Preparat złożony inhibitora wymiany sód-wodór kariporidu z inhibitorami ACE dla zapobiegania niewydolności serca i innych związanych z wiekiem dysfunkcji narządów, związanych z wiekiem chorób i dla przedłużenia życia

Country Status (23)

Country Link
EP (1) EP1474134B1 (pl)
JP (1) JP4733348B2 (pl)
KR (1) KR20040083498A (pl)
CN (1) CN1319528C (pl)
AR (1) AR038387A1 (pl)
AT (1) ATE520398T1 (pl)
AU (1) AU2003244430A1 (pl)
BR (1) BR0307443A (pl)
CA (1) CA2474888A1 (pl)
CO (1) CO5601009A2 (pl)
HR (1) HRP20040702A2 (pl)
HU (1) HUP0402593A2 (pl)
MA (1) MA27170A1 (pl)
MX (1) MXPA04007569A (pl)
NO (1) NO20043698L (pl)
NZ (1) NZ534479A (pl)
PE (1) PE20040188A1 (pl)
PL (1) PL370488A1 (pl)
RS (1) RS68204A (pl)
RU (1) RU2004126702A (pl)
TW (1) TW200306850A (pl)
WO (1) WO2003066045A1 (pl)
ZA (1) ZA200406066B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2552331B1 (en) * 2010-03-31 2020-01-08 The Hospital For Sick Children Use of remote ischemic conditioning to improve outcome after myocardial infarction

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0855392A3 (de) * 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19734693A1 (de) * 1997-08-11 1998-01-22 Hoechst Marion Roussel De Gmbh Verwendung von Cariporide als Inhibitor des zellulären NA+/H+-Exchangers (NHE) zur Herstellung eines Medikaments zur Behandlung von cardialen und nichtcardialen Krankheiten
DE19737224A1 (de) * 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
DE19859727A1 (de) * 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung

Also Published As

Publication number Publication date
EP1474134B1 (de) 2011-08-17
CA2474888A1 (en) 2003-08-14
NO20043698L (no) 2004-08-31
AR038387A1 (es) 2005-01-12
CO5601009A2 (es) 2006-01-31
AU2003244430A1 (en) 2003-09-02
CN1319528C (zh) 2007-06-06
WO2003066045A1 (de) 2003-08-14
MXPA04007569A (es) 2004-11-01
EP1474134A1 (de) 2004-11-10
NZ534479A (en) 2006-03-31
RU2004126702A (ru) 2005-04-20
BR0307443A (pt) 2005-01-04
ATE520398T1 (de) 2011-09-15
JP4733348B2 (ja) 2011-07-27
PE20040188A1 (es) 2004-05-17
TW200306850A (en) 2003-12-01
MA27170A1 (fr) 2005-01-03
RS68204A (en) 2007-02-05
ZA200406066B (en) 2005-06-08
HUP0402593A2 (hu) 2005-04-28
CN1694697A (zh) 2005-11-09
KR20040083498A (ko) 2004-10-02
HRP20040702A2 (en) 2005-04-30
JP2005519072A (ja) 2005-06-30

Similar Documents

Publication Publication Date Title
EP1509507A4 (en) INHIBITORS OF MITOTIC KINESIN
PL370478A1 (pl) Pochodne aminoindazolu jako inhibitory kinaz białkowych
BR0209948A (pt) Inibidores de fator inibitório de migração de macrófago e métodos para identificar os mesmos
MY142846A (en) Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
NO20044095L (no) 5-fenyltiazolderivater og anvendelse som P13 kinaseinhibitorer
EG26404A (en) Piperazine with –OR replacement Place the phenyl group and use it as a GIyT1 inhibitor
AU2003300021A8 (en) Thiosemicarbazones as anti-virals and immunopotentiators
ZA200501913B (en) New compounds for the inhibition of rotamases and use thereof
IS2529B (is) Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar
NO20053356L (no) Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
MXJL06000006A (es) Derivados de naftiridina sustituidos como inhibidores del factor inhibidor de la migracion de macrofagos y su uso en el tratamiento de enfermedades en el hombre.
IL165515A0 (en) Bisindolyl-maleimid derivatives as kinase inhibitors
EP1581497A4 (en) INHIBITORS OF MITOTIC KINESINE
HK1076039A1 (en) Methods for preserving organs and tissues
HK1077762A1 (zh) TFGß[轉化生長因子]的抑制劑
EP1578724A4 (en) INHIBITORS OF MITOTIC KINESINE
EP1786428A4 (en) PDE5 INHIBITOR COMPOSITIONS AND METHOD FOR TREATING DISEASE
WO2007109251A3 (en) Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
HK1080849A1 (en) Non-nucleoside reverse transcriptase inhibitors
IL172018A0 (en) Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases
PL374893A1 (pl) Pochodne 1-(4-benzylo-piperazyn-1-ylo)-3-fenylo-propenonu
AU2003230392A8 (en) Beta-secretase inhibitors
PL370488A1 (pl) Preparat złożony inhibitora wymiany sód-wodór kariporidu z inhibitorami ACE dla zapobiegania niewydolności serca i innych związanych z wiekiem dysfunkcji narządów, związanych z wiekiem chorób i dla przedłużenia życia
WO2003066885A3 (en) Method for screening for compounds having hdac inhibitory activity
AU2003251271A1 (en) USE OF Itk INHIBITORS FOR THE TREATMENT OF MAST CELL-DRIVEN OR BASOPHIL-DRIVEN DISEASES

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)